References
- Staton G W, Ingram R H. Disorders of the chest wall. ACP Medicine 2004. WebMD Inc., New York, NY 2004; 2
- Imai T, Matsumato H. Insidious phrenic nerve involvement in postpolio syndrome. Intern Med 2006; 45: 563–564, [E-pub 206 May 15]
- Janda A. Neurological complications secondary to subclavian venipuncture. Anesthesist 1981; 30: 148–149
- Rumbak M J, Chokshi S K, Abel N, Abel W, Kittusamy P K, McCormack J, et al. Left phrenic nerve paresis complicating catheter radiofrequency ablation for Wolff – Parkinson – White syndrome. Am Heart J 1996; 132: 1281–1285
- Koscielniak-Nielson Z J. Hemidiaphragmatic paresis after interscalene supplementation of insufficient axillary block with 3 ml of 2% mepivacaine. Acta Anaesthesiol Scand 2000; 44: 1160–1162
- Wheeler W E, Rubis L J, Jones C W, Harrah J D. Etiology and prevention of topical cardiac hypothermia-induced phrenic nerve injury and left lower lobe atelectasis during cardiac surgery. Chest 1985; 88: 680–683
- Rice A L, Ullal J, Vinik A I. Reversal of phrenic nerve palsy with topiramate. Diabetes Complications 2007; 21: 63–67
- Legha S S. Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol 1986; 1: 421–427
- Toker E, Yenice D, Ogut M S. Isolated abducens nerve palsy induced by vincristine therpy. J AAPOS 2004; 8: 69–71
- Rezvani K, Bain B J, Coulter C A. Loss of singing ability caused by vincristine. Clin Lab Haematol 1998; 20: 47–48
- Quasthoff S, Hartung H P. Chemotherapy-induced peripheral neuropathy. J Neurol 2002; 249: 9–17
- Bermudez M, Fuster J L, Linares E, Galera A, Gonzalez C. Intraconazole-related increased vincristine neurotoxicity: case report and review of literature. J Pediatr Hematol Oncol 2005; 27: 389–392
- Chauvenet AR, Shashi V, Salsky C, Morgan E, Kurtzberg J, Bell B, Pediatric Oncology Group Study. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: A Pediatric Oncology Group Study. J Pediatr Hematol Oncol 2003 Apr;25:316 – 320.
- Naumann R, Mohm J, Reuner U, Kroschinsky F, Rautenstrauss B, Ehninger G. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity. Br J Haematol 2001; 115: 323–325